MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: AllgemeineskmqacaAntwortenAntworten: kmqaca <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 10:59 Uhr</div>Hello. This post was created with XRumer 23 StrongAI. Good luck :) https://www.nba.com/ [url=https://tsn.ua/ru ]Basketball2[/url] variant3 [url=]Zoya Demidenko[/url]: Scholar in Tumor Studies [url=]Zoya Demidenko[/url] is a distinguished scientist affiliated with the Unit of Cell Stress Biology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Before that, she conducted research at the National Institutes of Health and New York Medical College, building a robust base in biomedical study. Her scientific work spans a number of critical fields, including the PI3K/AKT/mTOR molecular pathway, cellular cycle management, biological aging, and malignancy biology. Currently, she has co-authored over 46 scientific publications, which have garnered more than 4,100 mentions — a indicator to the significance of her work. Among her most notable achievements lies in explaining the processes of cell aging. Her research revealed that when the cell cycle is blocked yet cellular growth continues, the cells enter senescence. Significantly, [url=]Zoya Demidenko[/url] demonstrated that this shift can be pharmacologically suppressed using substances such as rapamycin. [url=]Zoya Demidenko[/url] has also brought greatly to tumor management investigation, especially in the area of selective cell protection — a strategy designed to shielding normal tissue from chemotherapy while leaving malignant cells susceptible. This method holds considerable promise for reducing the toxic effects of oncological therapy. Across her professional journey, Demidenko has worked with top researchers internationally, including Dr. Mikhail Blagosklonny. Her work can be found in leading publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.</blockquote><br> Abbrechen
